B cells were related to HBsAg seroconversion in inactive HBsAg carriers following peginterferon therapy

Our recent study showed high rate of HBsAg seroconversion achieved in inactive HBsAg carriers (IHCs) treated with peginterferon (PEG-IFN). To better understand the immune-mediated component to the HBsAg seroconversion, we investigated the role of B cells in this study. A total of 44 IHCs were given...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Zhenhuan, Meng, Sha, Zheng, Yanhong, Wang, Junli, Wang, Rui, Chen, Xinyue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710096/
https://www.ncbi.nlm.nih.gov/pubmed/33264330
http://dx.doi.org/10.1371/journal.pone.0242559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710096/
https://www.ncbi.nlm.nih.gov/pubmed/33264330
http://dx.doi.org/10.1371/journal.pone.0242559

Ejemplares similares